Surgery Partners, Inc.
SGRY
$17.07
$0.010.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.57% | 6.47% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.57% | 6.47% | |||
| Cost of Revenue | -0.70% | 2.69% | |||
| Gross Profit | -0.15% | 20.82% | |||
| SG&A Expenses | -37.95% | 0.28% | |||
| Depreciation & Amortization | -1.99% | 11.02% | |||
| Other Operating Expenses | 19.05% | -- | |||
| Total Operating Expenses | -2.62% | 2.70% | |||
| Operating Income | 11.38% | 35.38% | |||
| Income Before Tax | -29.68% | 14,700.00% | |||
| Income Tax Expenses | 600.00% | -- | |||
| Earnings from Continuing Operations | -43.65% | 15,066.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -1.27% | -26.74% | |||
| Net Income | -808.00% | 93.37% | |||
| EBIT | 11.38% | 35.38% | |||
| EBITDA | 8.04% | 28.36% | |||
| EPS Basic | -806.09% | 93.38% | |||
| Normalized Basic EPS | 32.85% | 37.06% | |||
| EPS Diluted | -800.00% | 93.33% | |||
| Normalized Diluted EPS | 32.85% | 37.06% | |||
| Average Basic Shares Outstanding | 0.18% | 0.30% | |||
| Average Diluted Shares Outstanding | 0.18% | 0.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||